Gkb Ophthalmics Ltd vs Indo Us Bio Tech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 30, 2026

Key Highlights

The Latest Trading Price of GKB Ophthalmics Ltd is ₹ 64 as of 30 Sep 15:30 . The P/E Ratio of GKB Ophthalmics Ltd changed from 36.4 on March 2022 to 23.6 on March 2026 . This represents a CAGR of -8.30% over 5 yearsThe P/E Ratio of Indo US Bio-Tech Ltd changed from 4 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of GKB Ophthalmics Ltd changed from ₹ 41.33 crore on March 2021 to ₹ 26.46 crore on March 2026 . This represents a CAGR of -7.16% over 6 yearsThe Market Cap of Indo US Bio-Tech Ltd changed from ₹ 19.75 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of GKB Ophthalmics Ltd for the Jun '26 is ₹ 33.77 crore as compare to the Mar '26 revenue of ₹ 30.6 crore. This represent the growth of 10.36% The revenue of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of GKB Ophthalmics Ltd for the Jun '26 is ₹ 3.36 crore as compare to the Mar '26 ebitda of ₹ 2.39 crore. This represent the growth of 40.59% The ebitda of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of GKB Ophthalmics Ltd changed from ₹ -0.04 crore to ₹ 1.85 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Indo US Bio-Tech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of GKB Ophthalmics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indo US Bio-Tech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About GKB Ophthalmics Ltd

Incorporated in December, 1981, GKB Opthalmics Limited was granted a licence as a 100% EOU in 1982.
The Company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Limited and The Maharashtra State Financial Corporation.
Presently, the Company is engaged in manufacture and sale of unfinished ophthalmic lenses and manufactures 14,000 pieces per day of plastic lenses. The company is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses.
Commercial production commenced in May '83.
It has an installed capacity of 30 lac lenses pa.

About Indo US Bio-Tech Ltd

Indo Us Bio-Tech Limited was originally incorporated as 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004.
Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005.
Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007.
Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops.
The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries.

FAQs for the comparison of GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd

Which company has a larger market capitalization, GKB Ophthalmics Ltd or Indo US Bio-Tech Ltd?

Market cap of GKB Ophthalmics Ltd is 32 Cr while Market cap of Indo US Bio-Tech Ltd is 154 Cr

What are the key factors driving the stock performance of GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd?

The stock performance of GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd?

As of September 30, 2026, the GKB Ophthalmics Ltd stock price is INR ₹64.0. On the other hand, Indo US Bio-Tech Ltd stock price is INR ₹77.12.

How do dividend payouts of GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd compare?

To compare the dividend payouts of GKB Ophthalmics Ltd and Indo US Bio-Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.